Literature DB >> 24827646

Perinatal neuroblastoma: a hidden bullet in the chest.

Harohalli Iyer Venkatesh1, Pankaj Kumar Mohanty1, Abdul Razak1, N Karthik Nagesh1.   

Abstract

A neonate with antenatally diagnosed intrathoracic mass by ultrasound scan was delivered uneventfully at 35 weeks gestation by caesarean section due to pre-eclampsia and fluctuating hypertension in the mother. The intrathoracic mass was echogenic and the diagnosis was inconclusive. At 12 h of life the baby deteriorated acutely, in terms of increased oxygen requirement, ventilatory care, heart rate fluctuation, hypotension requiring inotropic support and died despite intensive care support. The parents were counselled that an autopsy would be invaluable in providing a diagnosis given the antenatal finding of an intrathoracic mass. The final diagnosis of neuroblastoma was performed at postmortem. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 24827646      PMCID: PMC4024552          DOI: 10.1136/bcr-2013-202350

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

1.  Infant cancer in the U.S.: histology-specific incidence and trends, 1973 to 1992.

Authors:  J G Gurney; J A Ross; D A Wall; W A Bleyer; R K Severson; L L Robison
Journal:  J Pediatr Hematol Oncol       Date:  1997 Sep-Oct       Impact factor: 1.289

2.  Congenital intrathoracic neuroblastoma presenting as persistent pulmonary hypertension in a newborn.

Authors:  Narongsak Nakwan; Chutima Smathakanee
Journal:  World J Pediatr       Date:  2011-08-07       Impact factor: 2.764

Review 3.  Prenatally diagnosed neuroblastoma.

Authors:  S Acharya; S Jayabose; S J Kogan; O Tugal; D Beneck; D Leslie; M Slim
Journal:  Cancer       Date:  1997-07-15       Impact factor: 6.860

Review 4.  Perinatal neuroblastoma.

Authors:  Jed G Nuchtern
Journal:  Semin Pediatr Surg       Date:  2006-02       Impact factor: 2.754

Review 5.  Neuroblastoma: biological insights into a clinical enigma.

Authors:  Garrett M Brodeur
Journal:  Nat Rev Cancer       Date:  2003-03       Impact factor: 60.716

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.